Scher, H. I., Morris, M. J., Stadler, W. M., Higano, C. S., Halabi, S., Smith, M. R., … Armstrong, A. J. (2015). The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC). In Journal of Clinical Oncology (Vol. 33, pp. 5000–5000). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.5000

Scher, Howard I., Michael J. Morris, Walter Michael Stadler, Celestia S. Higano, Susan Halabi, Matthew Raymond Smith, Ethan M. Basch, et al. “The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC).” In Journal of Clinical Oncology, 33:5000–5000. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.5000.

Scher HI, Morris MJ, Stadler WM, Higano CS, Halabi S, Smith MR, et al. The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5000–5000.

Scher, Howard I., et al. “The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC).” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 5000–5000. Crossref, doi:10.1200/jco.2015.33.15_suppl.5000.

Scher HI, Morris MJ, Stadler WM, Higano CS, Halabi S, Smith MR, Basch EM, Fizazi K, Ryan CJ, Antonarakis ES, Corn PG, Liu G, De Bono JS, Schwartz LH, Beer TM, Kelly WK, Hussain M, Sartor AO, Kantoff PW, Armstrong AJ. The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5000–5000.